Lactobacillus Reuteri (DSM 17938) In Infants With Functional Chronic Constipation: A Double-blind, Randomized, Placebo-controlled Study
Notes for this study:
|Number of Subjects
_L. reuteri_ DSM 17938 (10^8^ CFU) in infants who are at least six months old but suffering from constipation noted that supplementation was able to increase bowel frequency at all tested time points (2, 4, and 8 weeks) relative to placebo treatment; stool consistency appeared to soften over the course of the 8 weeks of supplementation, but the softening was not significantly different than placebo.
The instances of inconsolable crying during this time did not differ between groups as both increased over the study period.